These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 34309766

  • 41. Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma.
    Ahmed N, Sriskandarajah P, Burd C, Riddell A, Boyd K, Kaiser M, Messiou C.
    Br J Radiol; 2019 May; 92(1097):20180822. PubMed ID: 30676781
    [Abstract] [Full Text] [Related]

  • 42. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients.
    Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, Ahlström H.
    Acta Radiol; 2011 Mar 01; 52(2):173-80. PubMed ID: 21498346
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.
    Kwee TC, van Ufford HM, Beek FJ, Takahara T, Uiterwaal CS, Bierings MB, Ludwig I, Fijnheer R, Nievelstein RA.
    Invest Radiol; 2009 Oct 01; 44(10):683-90. PubMed ID: 19724232
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Diffusion-weighted MRI: role in detecting abdominopelvic internal fistulas and sinus tracts.
    Schmid-Tannwald C, Agrawal G, Dahi F, Sethi I, Oto A.
    J Magn Reson Imaging; 2012 Jan 01; 35(1):125-31. PubMed ID: 21953793
    [Abstract] [Full Text] [Related]

  • 49. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
    Zhang Y, Xiong X, Fu Z, Dai H, Yao F, Liu D, Deng S, Hu C.
    Eur J Radiol; 2019 Nov 01; 120():108695. PubMed ID: 31589995
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.
    Lecouvet FE, Pasoglou V, Van Nieuwenhove S, Van Haver T, de Broqueville Q, Denolin V, Triqueneaux P, Tombal B, Michoux N.
    Eur Radiol; 2020 Jun 01; 30(6):3083-3093. PubMed ID: 32065282
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
    Albano D, Patti C, La Grutta L, Agnello F, Grassedonio E, Mulè A, Cannizzaro G, Ficola U, Lagalla R, Midiri M, Galia M.
    Eur J Radiol; 2016 Feb 01; 85(2):313-8. PubMed ID: 26781135
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M, Holzapfel K, Ganter C, Epple K, Metz S, Geinitz H, Kübler H, Gaa J, Rummeny EJ, Beer AJ.
    J Magn Reson Imaging; 2011 May 01; 33(5):1160-70. PubMed ID: 21509875
    [Abstract] [Full Text] [Related]

  • 57. Comparison of four MRI protocols for detection of extrahepatic colorectal cancer metastases.
    Sivesgaard K, Jöhnk ML, Larsen LP, Sørensen M, Kramer S, Løgager VB, Hansen F, Pedersen EM.
    J Magn Reson Imaging; 2017 Dec 01; 46(6):1619-1630. PubMed ID: 28301099
    [Abstract] [Full Text] [Related]

  • 58. [Tumor search with diffusion-weighted imaging--first experience].
    Bohlscheid A, Nuss D, Lieser S, Busch HP.
    Rofo; 2008 Apr 01; 180(4):302-9. PubMed ID: 18370348
    [Abstract] [Full Text] [Related]

  • 59. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY, Kim KW, Yoon MA, Lee MH, Chae EJ, Lee JH, Chung HW, Yoon DH.
    Cancer Imaging; 2020 Jan 30; 20(1):14. PubMed ID: 32000858
    [Abstract] [Full Text] [Related]

  • 60. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS.
    Acta Radiol; 2008 May 30; 49(4):427-35. PubMed ID: 18415787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.